Shufro Rose & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.4M | Buy |
57,739
+502
| +0.9% | +$272K | 1.93% | 15 |
|
|
2025
Q4 | $33.2M | Buy |
57,237
+770
| +1% | +$435K | 2.24% | 14 |
|
|
2025
Q3 | $28.1M | Sell |
56,467
-812
| -1% | -$378K | 2.29% | 12 |
|
|
2025
Q2 | $28.5M | Sell |
57,279
-545
| -0.9% | -$228K | 2.29% | 12 |
|
|
2025
Q1 | $28.8M | Sell |
57,824
-916
| -2% | -$496K | 2.27% | 12 |
|
|
2024
Q4 | $30.6M | Sell |
58,740
-965
| -2% | -$531K | 2.36% | 11 |
|
|
2024
Q3 | $33M | Hold |
59,705
| – | – | 2.68% | 10 |
|
|
2024
Q2 | $33M | Sell |
59,705
-910
| -2% | -$521K | 2.68% | 10 |
|
|
2024
Q1 | $35.2M | Sell |
60,615
-601
| -1% | -$337K | 2.91% | 7 |
|
|
2023
Q4 | $31M | Sell |
61,216
-210
| -0.3% | -$102K | 2.94% | 7 |
|
|
2023
Q3 | $31.1M | Buy |
61,426
+292
| +0.5% | +$156K | 2.93% | 7 |
|
|
2023
Q2 | $31.9M | Buy |
61,134
+175
| +0.3% | +$94.4K | 2.91% | 8 |
|
|
2023
Q1 | $35.1M | Sell |
60,959
-3,496
| -5% | -$1.97M | 3.25% | 5 |
|
|
2022
Q4 | $35.5M | Sell |
64,455
-32
| -0% | -$17K | 3% | 5 |
|
|
2022
Q3 | $32.7M | Sell |
64,487
-1,164
| -2% | -$651K | 3.27% | 3 |
|
|
2022
Q2 | $35.7M | Sell |
65,651
-3,641
| -5% | -$2M | 3.09% | 5 |
|
|
2022
Q1 | $40.9M | Sell |
69,292
-2,899
| -4% | -$1.67M | 3.16% | 5 |
|
|
2021
Q4 | $48.2M | Sell |
72,191
-2,007
| -3% | -$1.25M | 3.48% | 5 |
|
|
2021
Q3 | $42.4M | Sell |
74,198
-5,094
| -6% | -$2.8M | 3.32% | 6 |
|
|
2021
Q2 | $40M | Sell |
79,292
-1,183
| -1% | -$558K | 3.01% | 7 |
|
|
2021
Q1 | $36.7M | Buy |
80,475
+4,642
| +6% | +$2.22M | 2.91% | 9 |
|
|
2020
Q4 | $35.3M | Sell |
75,833
-662
| -0.9% | -$310K | 2.96% | 6 |
|
|
2020
Q3 | $33.8M | Sell |
76,495
-308
| -0.4% | -$127K | 3.25% | 6 |
|
|
2020
Q2 | $27.8M | Sell |
76,803
-499
| -0.6% | -$167K | 2.75% | 8 |
|
|
2020
Q1 | $21.9M | Buy |
77,302
+19,098
| +33% | +$6.02M | 2.61% | 9 |
|
|
2019
Q4 | $18.9M | Sell |
58,204
-842
| -1% | -$255K | 1.71% | 21 |
|
|
2019
Q3 | $17.2M | Buy |
59,046
+237
| +0.4% | +$67.9K | 1.7% | 17 |
|
|
2019
Q2 | $17.3M | Buy |
58,809
+250
| +0.4% | +$68.9K | 1.68% | 19 |
|
|
2019
Q1 | $16M | Sell |
58,559
-133
| -0.2% | -$33.1K | 1.6% | 18 |
|
|
2018
Q4 | $13.1M | Sell |
58,692
-730
| -1% | -$171K | 1.45% | 22 |
|
|
2018
Q3 | $14.5M | Sell |
59,422
-410
| -0.7% | -$94.3K | 1.35% | 23 |
|
|
2018
Q2 | $12.4M | Sell |
59,832
-305
| -0.5% | -$64.7K | 1.18% | 26 |
|
|
2018
Q1 | $12.4M | Sell |
60,137
-210
| -0.3% | -$44.1K | 1.23% | 25 |
|
|
2017
Q4 | $11.5M | Sell |
60,347
-585
| -1% | -$112K | 1.13% | 28 |
|
|
2017
Q3 | $11.5M | Sell |
60,932
-100
| -0.2% | -$18.1K | 1.16% | 27 |
|
|
2017
Q2 | $10.6M | Sell |
61,032
-275
| -0.4% | -$46.2K | 1.14% | 27 |
|
|
2017
Q1 | $9.42M | Buy |
61,307
+5,976
| +11% | +$913K | 1.02% | 31 |
|
|
2016
Q4 | $7.81M | Sell |
55,331
-425
| -0.8% | -$62.7K | 0.87% | 36 |
|
|
2016
Q3 | $8.87M | Sell |
55,756
-6,726
| -11% | -$1.04M | 0.99% | 33 |
|
|
2016
Q2 | $9.23M | Sell |
62,482
-8,046
| -11% | -$1.19M | 1.02% | 30 |
|
|
2016
Q1 | $9.99M | Buy |
70,528
+6,496
| +10% | +$871K | 1.12% | 29 |
|
|
2015
Q4 | $9.08M | Sell |
64,032
-50
| -0.1% | -$6.67K | 1.04% | 32 |
|
|
2015
Q3 | $7.83M | Sell |
64,082
-378
| -0.6% | -$49.2K | 0.94% | 38 |
|
|
2015
Q2 | $8.36M | Sell |
64,460
-565
| -0.9% | -$73.7K | 0.89% | 42 |
|
|
2015
Q1 | $8.73M | Sell |
65,025
-1,085
| -2% | -$140K | 0.9% | 41 |
|
|
2014
Q4 | $8.28M | Sell |
66,110
-350
| -0.5% | -$42.6K | 0.84% | 44 |
|
|
2014
Q3 | $8.09M | Sell |
66,460
-55
| -0.1% | -$6.69K | 0.84% | 43 |
|
|
2014
Q2 | $7.85M | Sell |
66,515
-180
| -0.3% | -$21.2K | 0.81% | 48 |
|
|
2014
Q1 | $8.02M | Sell |
66,695
-300
| -0.4% | -$35.7K | 0.84% | 42 |
|
|
2013
Q4 | $7.46M | Sell |
66,995
-56,620
| -46% | -$5.63M | 0.79% | 44 |
|
|
2013
Q3 | $11.4M | Sell |
123,615
-105
| -0.1% | -$9.5K | 1.3% | 23 |
|
|
2013
Q2 | $10.5M | Buy |
+123,720
| New | +$10.3M | 1.24% | 26 |
|
Other funds holding TMO
VCM
Shufro Rose & Co's TMO Position: Q1 2026 in Review
Shufro Rose & Co increased its Thermo Fisher Scientific (TMO) stake by 0.88% in Q1 2026, buying an estimated $272K and bringing the position to 57,739 shares worth $28.4M. The position accounts for 1.93% of the portfolio, ranked #15.
Shufro Rose & Co first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.2M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Shufro Rose & Co held 57,739 shares of Thermo Fisher Scientific worth $28.4M as of Q1 2026.
- Shufro Rose & Co bought 502 Thermo Fisher Scientific shares in Q1 2026, an estimated $272K.
- Thermo Fisher Scientific made up 1.93% of Shufro Rose & Co's portfolio in Q1 2026, its #15 holding.
- Shufro Rose & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Shufro Rose & Co's Thermo Fisher Scientific position peaked at $48.2M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Shufro Rose & Co's 13F filing for Q1 2026, filed 15 May 2026.